Translocation t(1;17) Disrupts Genes in Neuroblastoma
Author Information
Author(s): Vandepoele Karl, Andries Vanessa, Van Roy Nadine, Staes Katrien, Vandesompele Jo, Laureys Geneviève, De Smet Els, Berx Geert, Speleman Frank, van Roy Frans
Primary Institution: Department for Molecular Biomedical Research, VIB, Ghent, Belgium
Hypothesis
The constitutional balanced translocation t(1;17)(p36.2;q11.2) may lead to neuroblastoma by disrupting or activating genes.
Conclusion
The disruption of the NBPF1 and ACCN1 genes in a neuroblastoma patient suggests these genes may play a role in suppressing tumor development.
Supporting Evidence
- The translocation disrupts the NBPF1 gene, which is part of a gene family associated with neuroblastoma.
- Expression profiling showed lower levels of NBPF1 in neuroblastoma cell lines with a deletion of chromosome 1p.
- Meta-analysis indicated a role for NBPF and ACCN1 in tumor aggressiveness.
Takeaway
A patient with neuroblastoma had a genetic change that might have caused the cancer by affecting two important genes.
Methodology
The study involved cloning translocation breakpoints and analyzing gene expression in neuroblastoma cell lines.
Limitations
The study was limited to one patient, and the exact role of the disrupted genes in neuroblastoma remains unclear.
Participant Demographics
One Belgian neuroblastoma patient.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website